Alterity Therapeutics (PRNAD) Receivables - Accured (2021)
Alterity Therapeutics (PRNAD) posted quarterly Receivables - Accured of $3.2 million for Q2 2021.
Alterity Therapeutics (PRNAD) Receivables - Accured (2021) Analysis & Trends
Alterity Therapeutics (PRNAD) has reported Receivables - Accured for 1 consecutive years, with $3.2 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Receivables - Accured changed N/A year-over-year to $3.2 million; the TTM figure through Jun 2021 stood at $3.2 million (changed N/A YoY), while the FY2021 annual figure was $3.1 million, changed N/A from the prior year.
- Receivables - Accured came in at $3.2 million for Q2 2021 at Alterity Therapeutics.
- The five-year high for Receivables - Accured was $3.2 million in Q2 2021, with the low at $3.2 million in Q2 2021.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 3.18 Mn |
| Jun 30, 2021 | 3.18 Mn |